Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
Winblad, Bengt, Prof, Andreasen, Niels, MD, Minthon, Lennart, Prof, Floesser, Annette, MSc, Imbert, Georges, PhD, Dumortier, Thomas, MSc, Maguire, R Paul, PhD, Blennow, Kaj, MD, Lundmark, Joens, MD, Staufenbiel, Matthias, PhD, Orgogozo, Jean-Marc, Prof, Graf, Ana, MD
Published in Lancet neurology (01.07.2012)
Published in Lancet neurology (01.07.2012)
Get full text
Journal Article